Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
.jpg?d=110x100 "User supplied image")
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR094F2
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 379.00
In Stock
USD 428.00
In Stock
USD 379.00
In Stock
Rabbit monoclonal anti-ST13 Antibody, clone OTIR191G8
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
ZCCHC24 mouse monoclonal antibody, clone OTI2E1 (formerly 2E1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 524.00
In Stock
Mouse Monoclonal alpha Tubulin Antibody (DM1A) - Microtubule Marker
| Applications | IHC, WB |
| Reactivities | Bovine, Chicken, Guinea Pig, Human, Mouse, Porcine, Rat, Xenopus |
| Conjugation | Unconjugated |
Anti-GAPDH mouse mAb (Loading control)
| Applications | WB |
| Reactivities | Human, Monkey, Mouse, Rat, Dog |
| Conjugation | Unconjugated |
Mouse Monoclonal Anti-Slo2.2 Antibody
| Applications | WB |
| Reactivities | Human (weak), Mouse, Rat |
| Conjugation | Unconjugated |
Mouse Monoclonal beta Tubulin Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Rat
Applications
- WB
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Filter by
Target Symbol
- VSNL1 (165)
- ALK (162)
- MAP2K1 (123)
- NME1 (99)
- JUN (90)
- MAP2K3 (90)
- GLI1 (87)
- ERBB2 (78)
- GADD45G (78)
- CTNNB1 (75)
- OTC (75)
- ABCB1 (72)
- VIM (70)
- PIK3C2A (66)
- NUMB (64)
- PCNA (60)
- TOP2A (60)
- EGFR (58)
- L1CAM (57)
- MAPK13 (57)
- UBE2E3 (57)
- SENP2 (54)
- TYMS (51)
- APP (47)
- SYP (46)
- BRAF (45)
- ALDH1L1 (43)
- MLH1 (43)
- NCAM1 (42)
- SPG7 (42)
- AKT1 (41)
- ABAT (40)
- BCL2 (40)
- NKX2-1 (40)
- AFAP1 (39)
- BCL10 (39)
- CNOT4 (39)
- F13A1 (39)
- LGR5 (39)
- SNAI2 (39)
- SQSTM1 (39)
- GFAP (38)
- BBOX1 (36)
- LOX (36)
- LPL (36)
- MIOX (36)
- MMP13 (36)
- PARVA (36)
- PIK3CG (36)
- PSMC3 (36)
- SDR9C7 (36)
- ZFP36 (36)
- MAPK1 (34)
- MTOR (34)
- STAT5A (34)
- ACAT2 (33)
- ARHGAP25 (33)
- CCM2 (33)
- DPP9 (33)
- KRAS (33)
- MAPK7 (33)
- MOB3B (33)
- NAB1 (33)
- NPR3 (33)
- NRBF2 (33)
- PDE4A (33)
- PIK3AP1 (33)
- PTPRE (33)
- RET (33)
- SOCS3 (33)
- STAT4 (33)
- TNNT2 (33)
- TTLL12 (33)
- UPRT (33)
- ZNF365 (33)
- KCNAB1 (32)
- CDK2 (31)
- LTA4H (31)
- MSI1 (31)
- PFKP (31)
- PSMA6 (31)
- ACSS2 (30)
- ATP6V1C2 (30)
- BAG5 (30)
- BTK (30)
- CBX8 (30)
- CRYAB (30)
- ENKUR (30)
- FBXO21 (30)
- FBXW7 (30)
- FOSB (30)
- HADH (30)
- HDHD2 (30)
- IGF2BP2 (30)
- KATNB1 (30)
- LDLRAP1 (30)
- LIMK1 (30)
- MAPKAPK5 (30)
- MCM2 (30)
- MEF2C (30)
Antibody Hosts
Isotypes
Carrier-free
Knockout (KO) Validation
Modifications
- Phospho-specific (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (12796)
- Transcription Factors (4040)
- Transmembrane (2399)
- Protein Kinase (2003)
- ES Cell Differentiation/IPS (1585)
- Protease (999)
- Stem cell - Pluripotency (986)
- Secreted Protein (775)
- Nuclear Hormone Receptor (394)
- Adult stem cells (381)
- Phosphatase (276)
- Embryonic stem cells (265)
- Cancer stem cells (235)
- Stem cell relevant signaling - DSL/Notch pathway (180)
- Stem cell relevant signaling - JAK/STAT signaling pathway (175)
- Induced pluripotent stem cells (128)
- Ion Channels: Other (117)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (88)
- GPCR (83)
- P450 (54)
- Stem cell relevant signaling - Wnt Signaling pathway (31)
- Ion Channels: Potassium (29)
- Ion Channels: Cys-loop Receptors (18)
- Ion Channels: Transient receptor potential (4)
- Ion Channels: Glutamate Receptors (2)
- Ion Channels: Sodium (2)
- Ion Channels: Calcium (1)
- Ion Channels: Cyclic nucleotide gated (1)
Pathways
- Metabolic pathways (2427)
- Pathways in cancer (1860)
- MAPK signaling pathway (1454)
- Focal adhesion (1160)
- Prostate cancer (982)
- Colorectal cancer (940)
- Neurotrophin signaling pathway (903)
- ErbB signaling pathway (898)
- Progesterone-mediated oocyte maturation (770)
- Insulin signaling pathway (767)
- Regulation of actin cytoskeleton (754)
- T cell receptor signaling pathway (735)
- Endometrial cancer (730)
- Toll-like receptor signaling pathway (725)
- B cell receptor signaling pathway (710)
- Pancreatic cancer (709)
- GnRH signaling pathway (674)
- Non-small cell lung cancer (666)
- Renal cell carcinoma (666)
- Fc epsilon RI signaling pathway (664)
- Melanoma (654)
- Glioma (652)
- Acute myeloid leukemia (618)
- Chronic myeloid leukemia (612)
- Purine metabolism (563)
- Chemokine signaling pathway (541)
- VEGF signaling pathway (541)
- Endocytosis (534)
- Cell cycle (532)
- Bladder cancer (529)
- Gap junction (507)
- Wnt signaling pathway (504)
- Adherens junction (446)
- Leukocyte transendothelial migration (442)
- Fc gamma R-mediated phagocytosis (434)
- Natural killer cell mediated cytotoxicity (434)
- Thyroid cancer (416)
- Oocyte meiosis (415)
- Epithelial cell signaling in Helicobacter pylori infection (410)
- Alzheimer's disease (407)
- Pyrimidine metabolism (405)
- Small cell lung cancer (401)
- Ubiquitin mediated proteolysis (386)
- Melanogenesis (383)
- Long-term potentiation (369)
- mTOR signaling pathway (354)
- Tight junction (350)
- Axon guidance (344)
- Long-term depression (339)
- Apoptosis (336)
- Jak-STAT signaling pathway (336)
- Amyotrophic lateral sclerosis (ALS) (331)
- Type II diabetes mellitus (323)
- Calcium signaling pathway (321)
- Glycolysis / Gluconeogenesis (310)
- Vascular smooth muscle contraction (295)
- Arginine and proline metabolism (293)
- Adipocytokine signaling pathway (291)
- Huntington's disease (284)
- Dorso-ventral axis formation (266)
- Pathogenic Escherichia coli infection (259)
- Hedgehog signaling pathway (258)
- Parkinson's disease (255)
- Basal cell carcinoma (250)
- Prion diseases (250)
- p53 signaling pathway (245)
- Valine (241)
- Proteasome (240)
- TGF-beta signaling pathway (238)
- leucine and isoleucine degradation (235)
- Cell adhesion molecules (CAMs) (227)
- Cytokine-cytokine receptor interaction (218)
- NOD-like receptor signaling pathway (211)
- RNA degradation (199)
- Spliceosome (199)
- Nucleotide excision repair (198)
- Phosphatidylinositol signaling system (196)
- Oxidative phosphorylation (190)
- Inositol phosphate metabolism (188)
- Alanine (172)
- aspartate and glutamate metabolism (172)
- Mismatch repair (170)
- DNA replication (167)
- Fatty acid metabolism (167)
- Pyruvate metabolism (166)
- Propanoate metabolism (161)
- Lysine degradation (160)
- Notch signaling pathway (160)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (158)
- Butanoate metabolism (157)
- Hypertrophic cardiomyopathy (HCM) (157)
- RIG-I-like receptor signaling pathway (156)
- Base excision repair (152)
- One carbon pool by folate (151)
- Dilated cardiomyopathy (142)
- Antigen processing and presentation (135)
- Glutathione metabolism (130)
- beta-Alanine metabolism (130)
- Tryptophan metabolism (123)
- Tyrosine metabolism (119)
- Primary immunodeficiency (117)
- ABC transporters (116)
- Glycine (116)
- serine and threonine metabolism (116)
- Histidine metabolism (115)
- PPAR signaling pathway (113)
- Vibrio cholerae infection (111)
- Maturity onset diabetes of the young (110)
- Arachidonic acid metabolism (100)
- Glycerolipid metabolism (99)
- Amino sugar and nucleotide sugar metabolism (98)
- Drug metabolism - cytochrome P450 (95)
- SNARE interactions in vesicular transport (95)
- Cardiac muscle contraction (94)
- Neuroactive ligand-receptor interaction (90)
- Citrate cycle (TCA cycle) (84)
- Circadian rhythm - mammal (83)
- Fructose and mannose metabolism (82)
- Pentose phosphate pathway (81)
- Porphyrin and chlorophyll metabolism (81)
- Terpenoid backbone biosynthesis (81)
- Drug metabolism - other enzymes (78)
- Metabolism of xenobiotics by cytochrome P450 (78)
- Starch and sucrose metabolism (77)
- Viral myocarditis (70)
- RNA polymerase (69)
- Fatty acid elongation in mitochondria (66)
- Ascorbate and aldarate metabolism (64)
- Methane metabolism (64)
- Lysosome (58)
- Regulation of autophagy (56)
- Cysteine and methionine metabolism (55)
- Hematopoietic cell lineage (54)
- ECM-receptor interaction (51)
- Glyoxylate and dicarboxylate metabolism (51)
- Retinol metabolism (51)
- Cytosolic DNA-sensing pathway (50)
- Renin-angiotensin system (49)
- Galactose metabolism (48)
- N-Glycan biosynthesis (48)
- Nicotinate and nicotinamide metabolism (48)
- Complement and coagulation cascades (47)
- Type I diabetes mellitus (45)
- Synthesis and degradation of ketone bodies (42)
- Systemic lupus erythematosus (41)
- Folate biosynthesis (40)
- Basal transcription factors (39)
- Selenoamino acid metabolism (39)
- Olfactory transduction (37)
- Glycerophospholipid metabolism (34)
- Nitrogen metabolism (34)
- Phenylalanine metabolism (33)
- Androgen and estrogen metabolism (30)
- Ribosome (30)
- Primary bile acid biosynthesis (29)
- Limonene and pinene degradation (28)
- Ether lipid metabolism (27)
- Sulfur metabolism (27)
- Homologous recombination (26)
- Caffeine metabolism (21)
- Other glycan degradation (21)
- Pantothenate and CoA biosynthesis (21)
- Sphingolipid metabolism (21)
- Riboflavin metabolism (19)
- Aminoacyl-tRNA biosynthesis (18)
- Thiamine metabolism (18)
- Vitamin B6 metabolism (18)
- Non-homologous end-joining (17)
- Cyanoamino acid metabolism (15)
- Autoimmune thyroid disease (13)
- Allograft rejection (12)
- Fatty acid biosynthesis (12)
- Glycosphingolipid biosynthesis - lacto and neolacto series (12)
- Graft-versus-host disease (12)
- Keratan sulfate biosynthesis (12)
- Taste transduction (12)
- Biosynthesis of unsaturated fatty acids (9)
- D-Glutamine and D-glutamate metabolism (9)
- Linoleic acid metabolism (9)
- Taurine and hypotaurine metabolism (9)
- Glycosaminoglycan degradation (6)
- O-Glycan biosynthesis (6)
- Protein export (6)
- Steroid biosynthesis (6)
- alpha-Linolenic acid metabolism (6)
- leucine and isoleucine biosynthesis (6)
- Pentose and glucuronate interconversions (5)
- Glycosphingolipid biosynthesis - ganglio series (3)
- Phenylalanine (3)
- Ubiquinone and other terpenoid-quinone biosynthesis (3)
- tyrosine and tryptophan biosynthesis (3)